T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$1.23B |
| 2 |
Service Corp International
SCI
|
+$639M |
| 3 |
NXP Semiconductors
NXPI
|
+$628M |
| 4 |
Advanced Micro Devices
AMD
|
+$623M |
| 5 |
NVIDIA
NVDA
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCN
Waste Connections
WCN
|
+$1.13B |
| 2 |
Exelon
EXC
|
+$799M |
| 3 |
Veralto
VLTO
|
+$730M |
| 4 |
Intuit
INTU
|
+$728M |
| 5 |
Intercontinental Exchange
ICE
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.23% |
| 2 | Healthcare | 21.6% |
| 3 | Consumer Discretionary | 13.06% |
| 4 | Industrials | 10.78% |
| 5 | Financials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
BridgeBio Pharma
BBIO
$16.2B
| – | – |
-276,369
| Closed | -$7M |
|
627
BRC Inc
BRCC
$224M
| – | – |
-1,908,354
| Closed | -$11.7M |
|
628
Certara
CERT
$1.22B
| – | – |
-3,354,430
| Closed | -$46.5M |
|
629
CG Oncology
CGON
$6.78B
| – | – |
-66,596
| Closed | -$2.1M |
|
630
Clearwater Paper
CLW
$359M
| – | – |
-341,307
| Closed | -$16.5M |
|
631
Charles River Laboratories
CRL
$13.6B
| – | – |
-112,725
| Closed | -$23.3M |
|
|
CTRA
632
DELISTED
Coterra Energy
CTRA
| – | – |
-11,745,718
| Closed | -$313M |
|
|
FYBR
633
DELISTED
Frontier Communications
FYBR
| – | – |
-4,299,507
| Closed | -$113M |
|
|
GRFS
634
Grifois
GRFS
$5.42B
| – | – |
-1,303,596
| Closed | -$8.21M |
|
|
HLVX
635
DELISTED
HilleVax
HLVX
| – | – |
-3,481,222
| Closed | -$50.3M |
|
636
HubSpot
HUBS
$10.7B
| – | – |
-27,695
| Closed | -$16.3M |
|
637
Hydrofarm Holdings
HYFM
$8.29M
| – | – |
-79,676
| Closed | -$550K |
|
638
International Seaways
INSW
$4.73B
| – | – |
-37,080
| Closed | -$2.19M |
|
639
Johnson & Johnson
JNJ
$628B
| – | – |
-2,384
| Closed | -$349K |
|
640
Knowles
KN
$3.33B
| – | – |
-743,918
| Closed | -$12.8M |
|
641
Leslie's
LESL
$7.66M
| – | – |
-255,538
| Closed | -$21.4M |
|
642
Metropolitan Bank Holding Corp
MCB
$1.18B
| – | – |
-311,894
| Closed | -$13.1M |
|
643
Moody's
MCO
$83.6B
| – | – |
-3,530
| Closed | -$1.49M |
|
644
Madrigal Pharmaceuticals
MDGL
$12.3B
| – | – |
-25,644
| Closed | -$7.18M |
|
645
Noble Corp
NE
$6.96B
| – | – |
-1,473,961
| Closed | -$65.8M |
|
646
Napco Security Technologies
NSSC
$1.4B
| – | – |
-1,852,061
| Closed | -$96.2M |
|
|
NVEE
647
DELISTED
NV5 Global
NVEE
| – | – |
-1,662,780
| Closed | -$38.6M |
|
|
PCH
648
DELISTED
PotlatchDeltic
PCH
| – | – |
-472,190
| Closed | -$18.6M |
|
649
Public Service Enterprise Group
PEG
$38B
| – | – |
-4,085
| Closed | -$302K |
|
650
Prologis
PLD
$135B
| – | – |
-1,555
| Closed | -$175K |
|
Similar funds
T. Rowe Price Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Investment Management held 663 positions worth $166B, up 4.7% from $158B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q3 2024 filing shows 43 new, 263 increased, 315 reduced and 41 closed positions. Its largest new stake was Willis Towers Watson: 1,570,828 shares worth $463M. The largest sale was Waste Connections, an estimated $1.13B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q3 2024 buy was Willis Towers Watson: 1,570,828 shares worth $463M.
- T. Rowe Price Investment Management added most to McKesson in Q3 2024, an estimated $1.23B increase.
- T. Rowe Price Investment Management's biggest Q3 2024 reduction was Waste Connections, cutting an estimated $1.13B.
- T. Rowe Price Investment Management fully exited Coterra Energy in Q3 2024, selling an estimated $313M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $166B portfolio in Q3 2024.
- T. Rowe Price Investment Management opened 43 new positions and closed 41 in Q3 2024.
- T. Rowe Price Investment Management's portfolio value rose 4.7% quarter-over-quarter to $166B.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.